Skip to main content

CAMEO Newsletter Issue 3

Spring 2025, Issue 3 - read it below or see a PDF of this issue. 

Thank you for your participation in CAMEO!

Participants and families like you have helped CAMEO successfully reach the halfway point for enrollment. We could not have done it without you - thank you! 

May 19 is World IBD Day

You can help raise awareness about inflammatory bowel diseases (IBD) like Crohn’s disease all around the world. Learn more at worldibdday.org

A Closer Look at the CAMEO MRE for Phase 2 Participants

Participants in Phase 2 are asked to have a follow-up MRE, or Magnetic Resonance Enterography, after 52 weeks. This test is the same one done at diagnosis. 

What is an MRE? A series of pictures taken using a large magnet. (It is not an X-ray.) 

Why is an MRE helpful in Phase 2? There are many ways that doctors evaluate whether the bowel has healed following therapy. A colonoscopy is the test that shows us whether the bowel lining has healed. But the bowel lining is only part of the bowel wall. A MRE helps doctors see if the other parts of the bowel wall (the muscle and surface covering) have healed. In CAMEO, we want to know if the whole bowel wall has healed, from lining to surface. 

The MRE helps provide crucial information. This information might help future pediatric patients get to remission faster. MRE images, along with all samples given by participants, are greatly appreciated. 

Summer Tip

Dehydration is a health complication of IBD like Crohn’s disease, according to the US Centers for Disease Control and Prevention (CDC)*. This summer, stay cool, drink enough water, and watch for signs of dehydration. Wear a hat and use sunscreen. Read more: https://www.cdc.gov/healthy-weight-growth/water-healthy-drinks/index.html

Thank you for your participation! You make the difference towards our goal to help put future pediatric patients on a faster path to remission.

 

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CAMEO (Clinical, endoscopic, and imaging outcomes of children newly diagnosed with Crohn’s disease) is funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research reported in this publication was supported under Award Number 1U01DK134356-01. cameostudy.org

*https://www.cdc.gov/inflammatory-bowel-disease/about/index.html